Comparison of temperature measurements in esophagus and urinary bladder in comatose patients after cardiac arrest undergoing mild therapeutic hypothermia by Umińska, Julia M. et al.
Address for correspondence: Julia M. Umińska, MD, Department of Cardiology and Internal Medicine, Collegium Medicum, 
Nicolaus Copernicus University, ul. M. Skłodowskiej-Curie 9, 85–094 Bydgoszcz, Poland, tel: +48 52 585 4023,  
fax: +48 52 585 49 4024, e-mail: julia@uminska.net
Received: 9.07.2018 Accepted: 21.07.2018
Comparison of temperature measurements 
in esophagus and urinary bladder in comatose 
patients after cardiac arrest undergoing 
mild therapeutic hypothermia
Julia M. Umińska1, Katarzyna Buszko1, Jakub Ratajczak1, Piotr Łach1, 
Krzysztof Pstrągowski1, Anita Dąbrowska1, Piotr Adamski1, 
Grzegorz Skonieczny2, Jacek Manitius1, Jacek Kubica1
1Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland 
2Ludwik Rydygier Voivodship Polyclinical Hospital, Torun, Poland
Abstract
Background: Mild therapeutic hypothermia (MTH) is a recommended method of treatment for coma-
tose out-of-hospital cardiac arrest (OHCA) survivors. However, the proper site of temperature measure-
ment in MTH is still not defined. The aim of this study was to compare temperature measurements in 
the esophagus and urinary bladder in comatose post-OHCA patients treated with MTH.
Methods: This temperature comparison protocol was a part of a prospective, observational, multicenter 
cohort study. The study population included 36 unconscious patients after resuscitation for OHCA. The 
patient’s core temperature was independently measured every hour during MTH in the urinary bladder 
and in the esophagus.
Results: The mean temperature was lower in the esophagus (differences during induction phase: 
1.04 ± 0.92°C, p < 0.0001; stabilization phase: 0.54 ± 0.39°C, p < 0.0001; rewarming phase:  
0.40 ± 0.47°C, p < 0.0001). Nevertheless, a strong correlation between both sites was found (R2 = 0.83,  
p < 0.001). The decrease in temperature observed in the esophagus during the induction phase was 
faster when compared with the urinary bladder (1.09 ± 0.71°C/h vs. 0.83 ± 0.41°C/h; p = 0.002). As 
a consequence, time to reach temperature < 34.0°C was longer when temperature was measured in the 
urinary bladder (the difference between medians of the time 1.0 [0–1.5] h, p < 0.001).
Conclusions: Urinary bladder temperature measurements may lag behind temperature changes meas-
ured in the esophagus. Monitoring temperature simultaneously in the esophagus and in the urinary 
bladder is an accessible and reliable combination, although esophageal measurements seem to better 
reflect the dynamics of temperature changes, thus it seems to be more appropriate for MTH control. 
ClinicalTrials.gov Identifier: NCT02611934. (Cardiol J XXXX; XX, X: xx–xx)
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Introduction
Several relatively small randomized studies 
involving unconscious cardiac arrest survivors 
showed a significant improvement in neurologic 
function and survival rate with mild therapeutic 
hypothermia (MTH) of a target temperature be-
tween 32°C and 34°C [1–3]. A favorable effect of 
MTH on survival and neurological outcome was 
confirmed in meta-analysis pooling data from 
non-randomized studies [4]. However, results of 
the largest available randomized trial published 
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by Nielsen et al. [5] did not show superiority of 
MTH at the targeted temperature of 33°C above 
fever prevention at a targeted temperature of 
36°C. Therefore, in the current European Society 
of Cardiology (ESC) guidelines for both strategies 
are proposed as equivalent for comatose cardiac 
arrest survivors [6].
Regardless of the target temperature, an ac-
curate temperature control during MTH is required 
[7]. Measurement of central circulation tempera-
ture or brain tissue temperature is difficult to ap-
ply in an emergency setting, therefore surrogate 
sites such as urinary bladder, rectum, tympanic 
membrane, or esophagus, are often used [8–11]. 
However, the current guidelines do not define the 
proper site of temperature measurement for MTH 
control. It is recommended that patients undergo-
ing hypothermia body core temperature should 
be measured at two different sites [12], band yet 
for feedback-controlled devices with endovas-
cular cooling catheters or surface cooling, only 
one temperature measurement site for automatic 
guidance of MTH is required [13]. Esophagus and 
urinary bladder are currently the most commonly 
used sites.
Based on the available data from studies 
with a low number of patients enrolled it was hy-
pothesized that the temperature measured in the 
urinary bladder is not accurate when compared 
to the esophageal temperature at the induction 
phase of MTH. As expected herein, lagging of 
measurements in urinary bladder is behind the 
core temperature change measured in esophagus.
The aim of this study was to perform a 24-h, 
complete (covering three MTH phases: induction, 
stabilization and warming) comparison of tempera-
ture measurements in the esophagus and urinary 
bladder in comatose patients after cardiac arrest 
treated with MTH.
Methods
Study design
This temperature comparison protocol was a 
part of a prospective, observational, multicenter 
cohort study entitled Mild Therapeutic Hypother-
mia for Patients with Acute Coronary Syndrome 
and Cardiac Arrest Treated with Percutaneous 
Coronary Intervention (the UNICORN trial) [14]. 
The study was conducted in accordance with the 
principles contained in the Declaration of Helsinki 
and Good Clinical Practice guidelines. The study 
was approved by the Ethics Committee of Nico-
laus Copernicus University in Torun, Collegium 
Medicum in Bydgoszcz (study approval reference 
number KB 615/2015).
Study population
The study population included 36 unconscious 
patients after resuscitation for out-of-hospital 
cardiac arrest (OHCA) with shockable rhythm 
presenting with acute coronary syndrome (ACS). 
Initially 42 patients were enrolled in the study, 
however 6 of them were eventually excluded from 
analysis due to a lack of complete data. Baseline 
characteristics of study participants are presented 
in Table 1.
After admission to the study center and confir-
mation of initial diagnosis, patients were screened 
for eligibility to the trial. All enrolled subjects were 
treated with MTH in addition to standard therapy 
baccording to the previously described protocol [14]. 
Inclusion criteria were defined as:
 — age ≥ 18 years;
 — OHCA survivor;
 — sustained return of spontaneous circulation 
(ROSC) for more than 20 min after resuscita-
tion;
 — unconsciousness with a score of ≤ 8 on the 
Glasgow Coma Scale after ROSC;
 — shockable initial rhythm;
 — diagnosis or suspicion of ACS.
The exclusion criteria included:
 — unwitnessed OHCA;
 — obvious or suspected pregnancy;
 — known serious infection before OHCA;
 — known bleeding diathesis;
 — confirmed or suspected internal bleeding;
 — confirmed or suspected acute stroke;
 — confirmed or suspected cerebral injury;
 — known serious neurological dysfunction before
OHCA (Cerebral Performance Category ≤ 4);
 — known serious disease making 180 days of 
survival unlikely;
 — hemodynamic instability with systolic blood 
pressure < 65 mmHg despite the treatment;
 — time delay from ROSC to MTH induction 
> 240 min;
 — asystole or pulseless electrical activity as the 
initial rhythm [14].
Treatment and temperature measurement
Mild therapeutic hypothermia was induced and 
maintained for 24 h at a target temperature of 33°C 
using Intravascular Temperature Management™, 
CoolGard 3000® (Zoll Circulation Inc., USA) and 
a MTH-dedicated catheter (Mon-a-Therm™ Foley 
Catheter with Temperature Sensor 400TM, Covidi- 
2 www.cardiologyjournal.org
Cardiology Journal XXXX, Vol. XX, No. X
ent Company, Ireland) introduced into the inferior 
vena cava through a femoral vein. The induction 
phase was supported by infusion of cold saline 
(0.9% solution of sodium chloride at the tempera-
ture of 4°C) and use of ice packs. The rewarming 
phase was conducted in an actively controlled 
manner (0.3°C per hour). The cooling device used 
urinary bladder temperature as feedback to guide 
changes in patient temperature.
Each patient’s core temperature was inde-
pendently measured every hour during the MTH 
procedure (including induction of hypothermia 
and rewarming phase) in the urinary bladder and 
in the lower one third of the esophagus using 
a dedicated monitor (Monitor Philips IntelliVue 
MP-60, temperature module M1029A, Philips 
Medical Systems, UK) and catheter (ER 400-9 
Level® Esophageal Temperature Probe Thermis-
tor, Smiths Medical ASD Inc., USA). Before every 
clinical application both probes were calibrated ex-
vivo and checked for measurement concordance.
All patients were mechanically ventilated with 
a concomitant continuous intravenous infusion of 
propofol and fentanyl for sedation and analgesia, 
and treated according to current ESC guidelines.
Sample size calculation
Based on a sample size calculation and data 
published by Lefrant et al. [15] and assuming 
a two-sided alpha value of 0.05, it was calculated 
that enrolment of 18 patients would provide a 95% 
power to detect significant differences between 
temperatures measured in the urinary bladder 
and the esophagus. To provide more reliable data, 
it was decided to double the minimum number of 
patients to be enrolled (n = 36).
Statistical analysis
Statistical calculations were performed using 
the Statistica 12.5 package (StatSoft, Tulsa, OK, 
USA). Due to the absence of normal distribution 
of data (as assessed by the Shapiro-Wilk test) all 
analyses were performed using nonparametric 
tests. The differences between paired medians 
were compared with the Wilcoxon signed rank 
test. The differences between medians together 
with lower and upper quartiles were quoted. In all 
cases, two-sided p-values < 0.05 were considered 
significant.
Results
The temperature was measured in all patients 
every hour during three phases of MTH (induc-
tion, stabilization and rewarming). In total 3286 
temperature measurements were analyzed (1643 
for each site — esophagus and urinary bladder). 
Table 1. Baseline characteristics of patients.
Variable Patients undergoing 
MTH procedure  
(n = 36)
Demographic characteristics
Age [years]  62.3 ± 12.9
Female 6 (16.7%)
Medical history
Diabetes mellitus 13 (36.1%)
Arterial hypertension 17 (47.2%)
Prior stroke 2 (5.6%)
Prior myocardial infarction 11 (30.5%)
Patient status on admission 
and in-hospital management
GCS on hospital admission:
3–4 points 25 (69.5%)
5–6 points 11 (30.6%)
7–8 points 0 (0.0%)
Shock on hospital admission 22 (61.1%)
LVEF on hospital admission [%] 32.6 ± 8.8
Underlying cause of OHCA:
STEMI 22 (61.2%)
NSTEMI 6 (16.7%)
Other 8 (22.2%)
Presence of CAD:
Single-vessel 10 (27.8%)
Multi-vessel 20 (55.6%)
Without significant 
coronary lesions
6 (16.7%)
Treatment with PCI 30 (83.3%)
Use of IABC 4 (11.1%)
Patient status on discharge
Survival rate 24 (66.6%)
CPC at discharge:
1 9 (25%)
2 6 (16.6%)
3 7 (19.4%)
4 2 (5.6%)
5 12 (33.3%)
Data are presented as mean ± standard deviation or number 
(percentages). CAD — coronary artery disease; CPC — Cerebral 
Performance Category; GCS — Glasgow Coma Score; IABC — 
intra-aortic balloon counterpulsation; LVEF — left ventricular 
ejection fraction; MTH — mild therapeutic hypothermia; NSTEMI — 
non-ST-segment elevation myocardial infarction; OHCA — out-of-
-hospital cardiac arrest; PCI — percutaneous coronary intervention; 
STEMI — ST-segment elevation myocardial infarction
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The mean temperature measured in the esopha-
gus was lower when compared with temperature 
in the urinary bladder during all three phases of 
MTH procedure (Figs. 1, 2). The greatest differ-
ence in temperature assessed at these sites was 
observed during the induction phase (difference of 
1.04 ± 0.92°C, p < 0.0001). Temperature differ-
ences between measurement sites at stabilization 
and rewarming phases were smaller than during 
induction, however these differences were also 
statistically significant (stabilization: difference 
of 0.54 ± 0.39°C, p < 0.0001; rewarming: differ-
ence of 0.40 ± 0.47°C, p < 0.0001). Nevertheless, 
a strong correlation between temperature meas-
urement sites was found (R2 = 0.8348, p < 0.001).
Figure 1. Mean temperatures at the induction, stabiliza-
tion and rewarming phase of mild therapeutic hypo-
thermia.
Figure 2. Temperatures measured in the esophagus and urinary bladder in patients undergoing mild therapeutic 
hypothermia.
The temperature measured in the esophagus 
decreased faster than in the urinary bladder during 
the induction phase (1.09 ± 0.71°C/h vs. 0.83 ± 
± 0.41°C/h; p = 0.002). As a consequence, time 
to reach hypothermia (< 34.0°C) was longer when 
temperature was measured in the urinary bladder 
than in the esophagus. The difference between 
medians of time to the target temperature at each 
site was 1.0 (0.5–1.5) hour with p < 0.001.
During the second phase of MTH, well man-
aged temperature stabilization was reached. The 
vast majority of measurements, regardless of 
measurement site, remained within target limits 
(32–34°C) (Figs. 1, 2).
Temporary velocities of temperature changes 
were greatest during the induction phase, smaller 
in the rewarming phase, while in the stabilization 
phase they remained close to zero.
The Bland-Altman plot of temperatures meas-
ured in the esophagus vs. temperatures measured 
in the urinary bladder confirmed substantial differ-
ences between both methods (Fig. 3).
Discussion
Although temperature of blood perfusing the 
hypothalamus is a reference of core body tempera-
ture, pulmonary artery temperature is considered 
the gold standard in critical care, because it has 
been shown to be closest to the temperature in 
the high internal jugular vein and core body tem-
perature [16]. Nevertheless, pulmonary artery 
catheterization is not routinely performed in 
intensive care patients. When evaluating possible 
surrogates for pulmonary artery temperature, it 
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was generally agreed that it would be desirable to 
have an accurate, easy-to-use monitoring. Yet, from 
a literature review it was evident that there is still 
much conflicting data regarding the best surrogate 
for measuring core temperature [11, 12, 16–18]. 
The main findings of this study were sig-
nificant differences in temperature measurements 
performed in the esophagus and urinary bladder 
during MTH procedure. The temperature in the 
esophagus was lower during hypothermia with the 
greatest differences observed during the induction 
phase. As a result, time to reach the target tem-
perature was approximately 1 h longer when the 
temperature was assessed in the urinary bladder 
compared with the esophagus.
Very few, low subject number and fragmentary 
studies comparing different methods of tempera-
ture monitoring during MTH are available [13, 17, 
19, 20]. Some reports suggest that urinary bladder 
site does not reflect real-time temperature changes 
when hypothermia is induced, and temperature 
changes at this location lag behind body core tem-
perature changes [17, 19]. This observation how-
ever, was not confirmed in other studies [15, 20].
Maintenance of the core temperature within 
32–34°C is one of the most important issues dur-
ing MTH. Lefrant et al. [15] showed that mean 
differences in blood temperature in the pulmonary 
artery vs. esophageal and urinary bladder tem-
Figure 3. Bland-Altman Plot analysis of temperature difference as measured in the esophagus and urinary bladder; 
CI — confidence interval; SD — standard deviation
peratures were 0.11 ± 0.30°C and –0.21 ± 0.20°C, 
respectively, in patients with temperatures which 
ranged from 33.7°C to 40.2°C. According to this 
study, urinary bladder measurement site is prefer-
able because its accuracy reaches ± 0.4°C in the 
most critically ill patients, while the esophageal 
temperature could be an alternative when urinary 
bladder temperature cannot be used as an esopha-
geal probe can easily be inserted in intubated and 
sedated patients. However, according to Shin et al. 
[13] the accuracy of urinary bladder temperature 
measurement during the induction phase was lower 
than at maintenance and rewarming phases. Erick-
son and Kirklin [18] found that when patients were 
normothermic, bladder temperature was slightly 
higher than pulmonary artery temperature, but this 
was reversed when patients became hypothermic.
Data originating from another study suggested 
that during rapid temperature change in patients 
undergoing cardiopulmonary bypass in deep hypother-
mia, nasopharyngeal, esophageal, and pulmonary nar-
tery temperatures corresponded with brain tempera-
ture with smaller mean differences than temperatures 
measured at the tympanic membrane, urinary bladder, 
rectum, axilla, and sole of the foot [8]. Nevertheless, 
the differences reported for deep hypothermia may 
not reflect the situation present in MTH.
Markota et al. [19] compared temperature 
changes measured in the esophagus and urinary 
www.cardiologyjournal.org 5
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bladder in 8 survivors of cardiac arrest at the induc-
tion phase of MTH with cold saline infusion. Target 
temperature was achieved significantly earlier in 
the esophagus as compared with the urinary blad-
der (33 ± 15 min vs. 63 ± 15 min; p = 0.006). The 
decrease in temperature measured in the esopha-
gus was much faster (3.27 ± 1.27°C/h vs. 1.6 ± 
± 0.89°C/h; p = 0.008) with the greatest differ-
ences after 30–35 min [19]. On the other hand, 
a study by Knapik et al. [20] comparing pulmo-
nary artery, nasopharyngeal, and urinary bladder 
temperatures in 12 OHCA survivors undergoing 
MTH found no differences between these sites. In 
that study, however, the induction of hypothermia 
was much longer (time to target temperature in 
esophagus was 4.2 ± 3.6 h). The mean cooling 
rate was 0.89 ± 0.96°C/h. The major limitation of 
both aforementioned studies was a low number of 
patients enrolled [19, 20]. Of note, the rate of tem-
perature decrease observed in urinary bladder in 
the present study was similar to the rate reported 
by Markota et al. [19] and by Knapik et al. [20].
According to results obtained by Krizanac 
et al. [17] in 20 patients undergoing MTH, the 
temperature difference between pulmonary artery 
and esophagus was 0.1 ± 0.1°C during the overall 
procedure of hypothermia and 0.2 ± 0.2°C during 
the induction phase. The respective differences 
between pulmonary artery and urinary bladder 
were 0.1 ± 0.2°C and 0.4 ± 0.3°C (p < 0.01 for 
all differences). These dissimilarities may result 
in serious differences of cooling duration and ac-
tual core temperature magnitude, when different 
temperature assessment sites are applied [17]. 
The current results confirmed this presumption, 
however showed much higher differences between 
temperatures measured in the esophagus and uri-
nary bladder, especially during induction of MTH. 
Thus, a cautious approach is warranted in order not 
to induce over-cooling when using urinary bladder 
temperature for hypothermia guidance.
According to available research, the present 
study has the highest number of systematic, 
complete (covering three MTH phases: induction, 
stabilization and warming) comparison of tempera-
ture measurements in the esophagus and urinary 
bladder in comatose patients after cardiac arrest 
treated with MTH.
Limitations of the study
The main limitation of this study was a lack of 
other temperature measurement sites, especially 
the pulmonary artery, which seems to be the most 
reliable site for core body temperature measure-
ment.
Conclusions
The temperature measured in the esophagus 
remains lower during all three phases of MTH 
procedure compared with temperature evaluated 
in the urinary bladder. However, during the stabi-
lization phase most measurements remain within 
target limits (32–34°C) regardless of the applied 
method.
Urinary bladder temperature measurements 
may lag behind temperature changes measured in 
the esophagus and time to reach target tempera-
ture may be longer when assessing temperature 
in the urinary bladder.
Monitoring temperature simultaneously in the 
esophagus and in the urinary bladder is an acces-
sible and reliable combination, although esophageal 
measurements seem to better reflect the dynamics 
of temperature changes, thus it seems to be more 
appropriate for MTH control.
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